PepGen presents FREEDOM-DM1 trial data for PGN-EDODM1 at IDMC-15

PepGen Inc.

PepGen Inc.

PEPG

0.00
  • PepGen flagged new clinical data from its PGN-EDODM1 program for myotonic dystrophy type 1, with results set for presentation at the 15th International Myotonic Dystrophy Consortium meeting on May 26-30, 2026, in Quebec.
  • The company plans to show analyses of individual patient mis-splicing, supported by natural history work intended to frame how mis-splicing changes in DM1.
  • A separate poster is slated to highlight the FREEDOM-DM1 trial, describing strong splicing correction from single doses of PGN-EDODM1 with an acceptable safety profile.
  • Additional single-dose data, alongside initial multiple ascending dose data, are scheduled for a May 26, 2026 Pharma Day presentation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PepGen Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260521566873) on May 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.